Sponsor:
Massachusetts General Hospital
Code:
NCT06138275
Conditions
Refractory Multiple Myeloma
Relapse Multiple Myeloma
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elranatamab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2024-04-15.